Cancer Research Meeting Calendar  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aubert, M.
Right arrow Articles by Mas, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aubert, M.
Right arrow Articles by Mas, E.
[Cancer Research 60, 1449-1456, March 1, 2000]
© 2000 American Association for Cancer Research


Tumor Biology

Restoration of {alpha}(1,2) Fucosyltransferase Activity Decreases Adhesive and Metastatic Properties of Human Pancreatic Cancer Cells1

Muriel Aubert, Laurence Panicot, Christian Crotte, Patrick Gibier, Dominique Lombardo, Marie-Odile Sadoulet and Eric Mas2

Institut National de la Santé et de la Recherche Médicale Unité 260, Faculté de Médecine, 13385 Marseille cedex 5 [M. A., L. P., C. C., D. L., M. O. S., E. M.], and Institut National de la Santé et de la Recherche Médicale Unité 119, 13009 Marseille [P. G.], France

The expression of {alpha}(1,2) fucosyltransferases that catalyze the fucose transfer to galactose of the N-acetyl(iso)lactosamine chain is decreased in human metastatic pancreatic cancer cells. {alpha}(2,3) Sialyltransferases catalyze the transfer of sialic acid to the same substrate to form, with {alpha}(1,3/1,4) fucosyltransferases, sialyl-Lewis a and sialyl-Lewis x determinants on cell surface that are involved in pancreatic metastatic invasion. The aim of this study was to determine whether this decrease of {alpha}(1,2) fucosyltransferase expression can favor the {alpha}(2,3) sialyltransferase activity to form metastatic sialyl-Lewis antigens. Restoration of {alpha}(1,2) fucosyltransferase activity in the human pancreatic cancer cell line BxPC-3 was obtained by selecting stable transfectants expressing FUT1. Overexpression of FUT1 in BxPC-3 cells resulted in a substantial reduction of sialyl-Lewis antigen expression that correlated with an increase of expression of Lewis y and H-type antigens on cell surface. The modified oligosaccharide structures were preferentially restricted to three major glycoproteins, which could in part be related to mucin-type glycoproteins. The reduction of sialyl-Lewis antigen expression was associated with an inhibition of adhesive properties to E-selectin and a decrease of gastrointestinal metastatic power of BxPC-3 cells after xenograft transplantation into nude mice. This study provides evidence that the expression level of {alpha}(1,2) fucosyltransferase may regulate the expression of sialyl-Lewis a and sialyl-Lewis x antigens and consequently could play an important role in metastatic properties of human pancreatic cancer cells.




This article has been cited by other articles:


Home page
Mol. Cell. ProteomicsHome page
U. Kuzmanov, N. Jiang, C. R. Smith, A. Soosaipillai, and E. P. Diamandis
Differential N-glycosylation of Kallikrein 6 Derived from Ovarian Cancer Cells or the Central Nervous System
Mol. Cell. Proteomics, April 1, 2009; 8(4): 791 - 798.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
R. Saldova, L. Royle, C. M Radcliffe, U. M Abd Hamid, R. Evans, J. N Arnold, R. E Banks, R. Hutson, D. J Harvey, R. Antrobus, et al.
Ovarian Cancer is Associated with Changes in Glycosylation in Both Acute-Phase Proteins and IgG
Glycobiology, December 1, 2007; 17(12): 1344 - 1356.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Enomoto, T. Oda, Y. Aoyagi, S. Sugiura, M. Nakajima, M. Satake, M. Noguchi, and N. Ohkohchi
Consistent Liver Metastases in a Rat Model by Portal Injection of Microencapsulated Cancer Cells
Cancer Res., December 1, 2006; 66(23): 11131 - 11139.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
N. Tokuda, Q. Zhang, S. Yoshida, S. Kusunoki, T. Urano, K. Furukawa, and K. Furukawa
Genetic mechanisms for the synthesis of fucosyl GM1 in small cell lung cancer cell lines
Glycobiology, October 1, 2006; 16(10): 916 - 925.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. I. Kawamura, R. Kawashima, R. Fukunaga, K. Hirai, N. Toyama-Sorimachi, M. Tokuhara, T. Shimizu, and T. Dohi
Introduction of Sda Carbohydrate Antigen in Gastrointestinal Cancer Cells Eliminates Selectin Ligands and Inhibits Metastasis
Cancer Res., July 15, 2005; 65(14): 6220 - 6227.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Mathieu, M. Prorok, A.-M. Benoliel, R. Uch, C. Langlet, P. Bongrand, R. Gerolami, and A. El-Battari
Transgene Expression of {alpha}(1,2)-Fucosyltransferase-I (FUT1) in Tumor Cells Selectively Inhibits Sialyl-Lewis x Expression and Binding to E-Selectin without Affecting Synthesis of Sialyl-Lewis a or Binding to P-Selectin
Am. J. Pathol., February 1, 2004; 164(2): 371 - 383.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
R. Peracaula, L. Royle, G. Tabares, G. Mallorqui-Fernandez, S. Barrabes, D. J. Harvey, R. A. Dwek, P. M. Rudd, and R. de Llorens
Glycosylation of human pancreatic ribonuclease: differences between normal and tumor states
Glycobiology, April 1, 2003; 13(4): 227 - 244.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
S. Marionneau, B. Le Moullac-Vaidye, and J. Le Pendu
Expression of histo-blood group A antigen increases resistance to apoptosis and facilitates escape from immune control of rat colon carcinoma cells
Glycobiology, December 1, 2002; 12(12): 851 - 856.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
S. Yazawa, T. Nishimura, M. Ide, T. Asao, A. Okamura, S. Tanaka, I. Takai, Y. Yagihashi, A. R. Saniabadi, and N. Kochibe
Tumor-related expression of {alpha}1,2fucosylated antigens on colorectal carcinoma cells and its suppression by cell-mediated priming using sugar acceptors for {alpha}1,2fucosyltransferase
Glycobiology, September 1, 2002; 12(9): 545 - 553.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Watanabe, C. Ohyama, H. Aoki, T. Takahashi, M. Satoh, S. Saito, S. Hoshi, A. Ishii, M. Saito, and Y. Arai
Ganglioside GM3 Overexpression Induces Apoptosis and Reduces Malignant Potential in Murine Bladder Cancer
Cancer Res., July 1, 2002; 62(13): 3850 - 3854.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Ikeda, H. Eguchi, S. Nishihara, H. Narimatsu, R. Kannagi, T. Irimura, M. Ohta, H. Matsuda, N. Taniguchi, and K. Honke
A Remodeling System of the 3'-Sulfo-Lewis a and 3'-Sulfo-Lewis x Epitopes
J. Biol. Chem., October 12, 2001; 276(42): 38588 - 38594.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.